Johnson K L, Cummings A M, Birnbaum L S
University of North Carolina, Chapel Hill 27599-7270, USA.
Environ Health Perspect. 1997 Jul;105(7):750-5. doi: 10.1289/ehp.97105750.
Previous studies showed exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (2,3,7,8-TCDD) enhances the development of endometriotic lesions. In this study we examined the effects of other polyhalogenated aromatic hydrocarbons on endometriotic proliferation. B6C3F1 female mice were treated via oral gavage a total of five times, with 3 weeks between each dosing, with 0, 1, 3, or 10 micrograms 2,3,7,8,-TCDD/kg body weight (bw); 3 or 30 mg 2,2',4,4',5,5'-hexachlorobiphenyl (PCB 153)/kg bw; 100, 300, or 1000 micrograms 3,3',4,4',5-pentachlorobiphenyl (PCB 126)/kg bw; 10, 30, or 100 micrograms 2,3,4,7,8-pentachlorodibenzofuran (4-PeCDF)/kg bw; or 2 or 20 mg 1,3,6,8-TCDD/kg at 10 ml/kg bw. Endometriosis was surgically induced during the week of the second dosing. Three weeks following the final dose, the mice were euthanized and endometriotic lesions, whole body, liver, ovaries, uterine horn, and thymus were weighted, and lesion diameters were measured. Lesions, uterine horns, and ovaries were fixed for histopathology and livers were processed for measurement of ethoxyresorufin O-deethylase (EROD) activity. Both 2,3,7,8-TCDD (1 and 3 micrograms/kg bw) and 4-PeCDF (100 micrograms/kg bw) significantly enhanced the growth of endometrial lesions. No statistically significant increase in endometriotic lesion size was detected in animals treated with either PCB 126 or with the highest dose of 2,3,7,8-TCDD, possibly due to the effects of histologically observed ovarian toxicity. The nondioxin-like compounds, PCB 153 and 1,3,6,8-TCDD, produced no observable effects on endometriosis. Hepatic EROD activity was significantly induced by 2,3,7,8-TCDD, 4-PeCDF, and PCB 126, but not by PCB 153 or 1,3,6,8-TCDD. The results of this study provide preliminary support for the hypothesis that halogenated aromatic hydrocarbon-promoted endometriosis may be Ah receptor mediated.
以往研究表明,接触2,3,7,8-四氯二苯并对二恶英(2,3,7,8-TCDD)会促进子宫内膜异位症病变的发展。在本研究中,我们检测了其他多卤代芳烃对子宫内膜异位症增殖的影响。将B6C3F1雌性小鼠通过灌胃给药,共给药五次,每次给药间隔3周,分别给予0、1、3或10微克2,3,7,8-TCDD/千克体重(bw);3或30毫克2,2',4,4',5,5'-六氯联苯(PCB 153)/千克bw;100、300或1000微克3,3',4,4',5-五氯联苯(PCB 126)/千克bw;10、30或100微克2,3,4,7,8-五氯二苯并呋喃(4-PeCDF)/千克bw;或2或20毫克1,3,6,8-TCDD/千克,剂量为10毫升/千克bw。在第二次给药周期间通过手术诱导子宫内膜异位症。末次给药后3周,对小鼠实施安乐死,并对子宫内膜异位症病变、全身、肝脏、卵巢、子宫角和胸腺进行称重,测量病变直径。将病变、子宫角和卵巢固定用于组织病理学检查,肝脏用于乙氧异吩唑酮O-脱乙基酶(EROD)活性测定。2,3,7,8-TCDD(1和3微克/千克bw)和4-PeCDF(100微克/千克bw)均显著促进子宫内膜病变的生长。在用PCB 126或最高剂量的2,3,7,8-TCDD处理的动物中,未检测到子宫内膜异位症病变大小有统计学意义的增加,这可能是由于组织学观察到的卵巢毒性作用。非二恶英类化合物PCB 153和1,3,6,8-TCDD对子宫内膜异位症未产生可观察到的影响。2,3,7,8-TCDD、4-PeCDF和PCB 126显著诱导肝脏EROD活性,但PCB 153或1,3,6,8-TCDD未诱导。本研究结果为卤代芳烃促进的子宫内膜异位症可能由芳烃受体介导这一假说提供了初步支持。